Agra Ventures Announces Appointment of Fiona Fitzmaurice to its Board of Directors
October 26, 2021 12:46 ET
|
Agra Ventures Ltd.
VANCOUVER, British Columbia, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth-oriented and diversified company...
Blockchain Foundry to Present at the World’s First Fantom Developer Conference
October 26, 2021 09:23 ET
|
Blockchain Foundry Inc.
TORONTO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Blockchain Foundry Inc. (“BCF”) (CSE:BCFN) is pleased to announce that it will be presenting at the Fantom Developer Conference (“FantomDC”) via...
VR completes 2021 drill program at Hecla-Kilmer and reports final data from 2020 which confirm the REE and critical metal discovery at H-K
October 26, 2021 09:00 ET
|
VR Resources
VANCOUVER, British Columbia, Oct. 26, 2021 (GLOBE NEWSWIRE) -- VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCQB: VRRCF), the "Company", or “VR”, announces that the fall 2021 drill program has been...
Victory Square Portfolio Company, GameOn Secures Three Additional Prediction Game Projects with MX Player for Soccer, Tennis & Kabaddi
October 26, 2021 08:45 ET
|
Victory Square Technologies Inc.
VANCOUVER, British Columbia, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory Square" or the "Company") (CSE:VST) (OTC:VSQTF) (FWB:6F6) a company that provides investors...
Enthusiast Gaming to Announce Third Quarter Financial Results on November 10, 2021
October 26, 2021 08:30 ET
|
Enthusiast Gaming Inc.
TORONTO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (NASDAQ:EGLX; TSX:EGLX) will report financial results for its third quarter ending...
Medexus to Present at the Benzinga Global Small Cap Conference on October 28, 2021
October 26, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and MONTREAL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d’Entremont, Chief...
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
October 26, 2021 08:15 ET
|
Revive Therapeutics Ltd.
DSMB support in continuing the Phase 3 clinical trial; No serious adverse events and safety concerns reported to date.Phase 3 clinical trial to incorporate viral load testing for a minimum of 300...
GSP Resource Corp. Commences Alwin Copper Mine Fall 2021 Drill Program
October 26, 2021 08:00 ET
|
GSP Resource Corp.
VANCOUVER, British Columbia, Oct. 26, 2021 (GLOBE NEWSWIRE) -- GSP Resource Corp. (TSX-V: GSPR) (FRA: 0YD) (the “Company” or “GSP”) announces that the Fall 2021 drilling campaign at the Alwin Mine...
Recce Pharmaceuticals Receives Ethics Approval to Start Phase I Intravenous Clinical Trial of RECCE® 327
October 26, 2021 08:00 ET
|
Recce Pharmaceuticals
Highlights: Phase I clinical trial of RECCE® 327 approved to start intravenous ascending-dose, randomized, placebo-controlled, parallel, double-blind, single-dose studyAccording to Pew Charitable...
Clearmind Signs Development and Supply Agreement to Produce Its Drug Candidate MEAI Psychedelic Molecule With Aragen Life Sciences
October 26, 2021 08:00 ET
|
Clearmind Medicine
TORONTO, Ontario, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...